Arthritis & Rheumatology Center of Oklahoma, PLLC

Oklahoma City, Oklahoma 73103

0 studies enrolling now · 9 studies all time

What they study most

Chronic Gout, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) — Completed
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® — Completed